Prestige V + VEE with Havlogen

Home > Equine Direct > EQ Vaccines > VEWTFR: Eastern, Western, & Venezualan Encephalomyelitis, Tetanus, Influenza & Rhinopneumonitis >

Prestige V + VEE with Havlogen, by Intervet Schering-Plough, is for the vaccination of healthy horses against Eastern, Western and Venezuelan encephalomyelitis, equine influenza types A1, A2, tetanus, and rhinopneumonitis (EHV-1 and EHV-4). For primary immunization give 1 ml intramuscularly and repeat in 3 to 4 weeks. Booster with a single dose annually and at any time epidemic conditions exist or are reported and exposure is imminent. Please allow 24-48 hours for single doses to ship.

Item#	Item Name	Our Price	Qty	Add
990-020229	Prestige V + VEE with Havlogen 10ds 10ml	$323.95	(Out of Stock)
990-020228	Prestige V + VEE with Havlogen Single Dose	$33.99	(Out of Stock)
Check the items you wish to purchase, then click

Extended Information:

PRESTIGE^® V + VEE WITH HAVLOGEN^®*

Intervet

Equine Vaccine

ENCEPHALOMYELITIS-RHINOPNEUMONITIS-INFLUENZA VACCINE

EASTERN, WESTERN AND VENEZUELAN, KILLED VIRUS

TETANUS TOXOID

A combination of inactivated, purified, concentrated, adjuvanted, tissue culture origin, Equine Encephalomyelitis Virus, Eastern, Western, and Venezuelan, Equine Herpesvirus EHV-1 and EHV-4, Equine Influenza Virus subtype A2 including KY93, KY02, and NM2/93 strains and Tetanus Toxoid. Intervet serological data suggest Influenza cross protection against certain U.S. and European strains, including Kentucky 91, 93, 99, 02, Ohio 93, Newmarket/1/93, Newmarket/2/93, Suffolk 89, and South Africa 03.

INDICATIONS: For vaccination of healthy horses, 6 months of age or older, as an aid in the prevention of Eastern, Western, and Venezuelan Encephalomyelitis and Tetanus, and as an aid in the control of respiratory disease caused by Equine Influenza Virus and Equine Herpesvirus and as an aid in the reduction of Influenza virus shedding. Duration of Immunity (DOI) has been shown to be at least 6 months for Influenza. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.

DOSE: For primary immunization aseptically inject 1 mL intramuscularly and repeat the dose in 3 to 4 weeks. Annual revaccination is recommended. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.

CAUTIONS: Store at 35° to 45°F (2° to 7°C). Shake well before using. Use entire contents when first opened (10 doses). Do not vaccinate within 21 days before slaughter. Local reactions may occur if this product is given subcutaneously. Inject deep into the muscle only. Anaphylactoid reactions may occur. ANTIDOTE: Epinephrine.